Education
About Us
Working with TipRanks
Follow Us
Monogram Orthopaedics Inc (MGRM)
NASDAQ:MGRM
RESEARCH TOOLSreports
Earnings Data
Report Date
May 20, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.11Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: 8.62%
|Next Earnings Date:May 20, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view of achievements and challenges. While the company has made significant technological advancements and maintains a strong cash position, uncertainties around regulatory approvals and capital needs for product launch temper the positive outlook.Company Guidance
During the Monogram Technologies conference call, CFO Noel Knape highlighted key financial metrics, including ending the year with a cash balance of $15.7 million, which was attributed to maintaining a monthly cash burn rate of approximately $1.2 million, a successful oversubscribed $13 million preferred D raise, and strategic investments by senior management. The company has a strong balance sheet and no traditional debt, allowing it to be well-prepared for upcoming milestones. Monogram has 27 full-time employees and uses outsourced engineering talent as needed, with a focus on optimizing cost structure. CEO Benjamin Sexson discussed the company's progress in robotic knee replacement technology, emphasizing the significance of their fully autonomous cutting system and the ongoing regulatory processes in both the U.S. and India. The call also touched on the expected timelines for clinical trials, the anticipated FDA decision, and future capital requirements for scaling operations.Strong Cash Position
Ended the year with a cash balance of $15.7 million, higher than the previous year, due to frugal spending and a successful oversubscribed $13 million preferred D raise.
Technological Advancements in Robotic Surgery
Developed an autonomous cutting system that can cut bone with high accuracy and speed, nearly a 300% increase in feed rate, making it competitive with manual surgery.
Regulatory Progress
Successfully responded to the FDA's questions and submitted for regulatory approval in India with ongoing communications.
---
MGRM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MGRM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $2.32 | $2.31 | -0.43% |
| Nov 14, 2024 | $2.01 | $2.05 | +1.99% |
| Aug 14, 2024 | $2.70 | $2.79 | +3.33% |
| May 14, 2024 | $1.90 | $2.03 | +6.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Monogram Orthopaedics Inc (MGRM) report earnings?
Monogram Orthopaedics Inc (MGRM) is schdueled to report earning on May 20, 2025, TBA Not Confirmed.
What is Monogram Orthopaedics Inc (MGRM) earnings time?
Monogram Orthopaedics Inc (MGRM) earnings time is at May 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MGRM EPS forecast?
MGRM EPS forecast for the fiscal quarter 2025 (Q1) is -0.1.
---